$HPK
HighPeak Energy, Inc. Stock $hpk

$hpk Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000143774922027261 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$257.9M	$204.1M	$47.47M
YoY Change	161.4%	329.97%	882.04%
Cost Of Revenue	$23.85M	$19.71M	$6.710M
YoY Change	108.78%	193.7%	906.0%
Gross Profit	$234.1M	$184.4M	$40.76M
YoY Change	168.3%	352.4%	878.21%
Gross Profit Margin	90.75%	90.35%	85.87%
Selling, General & Admin	$10.78M	$1.877M	$1.666M
YoY Change	41.36%	12.67%	104.17%
% of Gross Profit	4.61%	1.02%	4.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$83.21M	$42.62M	$13.92M
YoY Change	287.68%	206.27%	498.07%
% of Gross Profit	35.55%	23.11%	34.14%
Operating Expenses	$107.2M	$1.877M	$1.666M
YoY Change	212.47%	12.67%	104.17%
Operating Profit	$126.9M	$118.3M	$21.96M
YoY Change	139.67%	438.78%	-258.82%
Interest Expense	-$38.97M	$14.61M	$947.0K
YoY Change	968.05%	1442.56%
% of Operating Profit	-30.72%	12.35%	4.31%
Other Income/Expense, Net	$0.00	$0.00	$0.00
YoY Change	-100.0%
Pretax Income	$87.90M	$139.5M	$10.19M
YoY Change	78.49%	1268.73%	-173.72%
Income Tax	$20.00M	$31.60M	$2.145M
% Of Pretax Income	22.76%	22.65%	21.05%
Net Earnings	$61.63M	$107.9M	$8.047M
YoY Change	66.44%	1240.92%	-169.88%
Net Earnings / Revenue	23.89%	52.86%	16.95%
Basic Earnings Per Share		$0.90	$0.07
Diluted Earnings Per Share	$0.53	$0.85	$0.08
COMMON SHARES
Basic Shares Outstanding	113.2M	109.2M	92.68M
Diluted Shares Outstanding		115.1M	92.68M

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$30.50M	$34.35M	$11.97M
YoY Change	-12.52%	187.05%	-78.2%
Cash & Equivalents	$30.50M	$34.35M	$11.97M
Short-Term Investments
Other Short-Term Assets	$4.150M	$22.95M	$2.642M
YoY Change	-55.87%	768.55%	-22.29%
Inventory	$13.28M	$8.181M	$3.920M
Prepaid Expenses	$4.133M	$5.686M	$2.592M
Receivables	$96.60M	$83.20M	$23.89M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$144.5M	$148.7M	$42.42M
YoY Change	66.21%	250.5%	-52.61%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.587M	$3.548M	$1.397M
YoY Change	124.19%	153.97%	220.41%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$6.431M	$6.656M	$4.928M
YoY Change	34.23%	35.06%
Total Long-Term Assets	$2.135B	$1.894B	$671.2M
YoY Change	191.66%	182.14%	48.33%
TOTAL ASSETS
Total Short-Term Assets	$144.5M	$148.7M	$42.42M
Total Long-Term Assets	$2.135B	$1.894B	$671.2M
Total Assets	$2.279B	$2.042B	$713.6M
YoY Change	178.34%	186.2%	31.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$105.6M	$124.0M	$12.35M
YoY Change	176.75%	904.46%	37.19%
Accrued Expenses	$120.9M	$101.3M	$29.85M
YoY Change	275.23%	239.42%	472.42%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$0.00
YoY Change
Total Short-Term Liabilities	$266.1M	$260.4M	$77.01M
YoY Change	158.38%	238.06%	171.58%
LONG-TERM LIABILITIES
Long-Term Debt	$704.3M	$561.8M	$93.10M
YoY Change	619.24%	503.38%
Other Long-Term Liabilities	$0.00	$0.00	$455.0K
YoY Change	-100.0%	-100.0%	-81.8%
Total Long-Term Liabilities	$704.3M	$561.8M	$93.56M
YoY Change	613.19%	500.44%	3642.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$266.1M	$260.4M	$77.01M
Total Long-Term Liabilities	$704.3M	$561.8M	$93.56M
Total Liabilities	$970.5M	$822.1M	$170.6M
YoY Change	381.01%	381.97%	193.58%
SHAREHOLDERS EQUITY
Retained Earnings	$160.7M	$95.96M	-$101.5M
YoY Change	-349.46%	-194.57%	11.77%
Common Stock	$11.00K	$11.00K	$9.000K
YoY Change	10.0%	22.22%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.170B	$1.101B	$489.9M
YoY Change
Total Liabilities & Shareholders Equity	$2.279B	$2.042B	$713.6M
YoY Change	178.34%	186.2%	31.66%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	$61.63M	$107.9M	$8.047M
YoY Change	66.44%	1240.92%	-169.88%
Depreciation, Depletion And Amortization	$83.21M	$42.62M	$13.92M
YoY Change	287.68%	206.27%	498.07%
Cash From Operating Activities	$201.2M	$154.6M	$40.46M
YoY Change	239.43%	282.18%	278.35%
INVESTING ACTIVITIES
Capital Expenditures	$321.7M	-$323.1M	-$64.64M
YoY Change	-494.05%	399.83%	-1.25%
Acquisitions
YoY Change
Other Investing Activities	-$17.34M	$28.89M	-$47.59M
YoY Change	-185.12%	-160.7%	-87.62%
Cash From Investing Activities	-$339.1M	-$294.2M	-$112.2M
YoY Change	453.36%	162.14%	167.01%
FINANCING ACTIVITIES
Cash Dividend Paid			$9.300M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	134.0M	151.5M	70.90M
YoY Change	438.24%	113.71%	-15.87%
NET CHANGE
Cash From Operating Activities	201.2M	154.6M	40.46M
Cash From Investing Activities	-339.1M	-294.2M	-112.2M
Cash From Financing Activities	134.0M	151.5M	70.90M
Net Change In Cash	-3.844M	11.93M	-876.0K
YoY Change	-116.78%	-1461.99%	-101.65%
FREE CASH FLOW
Cash From Operating Activities	$201.2M	$154.6M	$40.46M
Capital Expenditures	$321.7M	-$323.1M	-$64.64M
Free Cash Flow	-$120.5M	$477.7M	$105.1M
YoY Change	-185.52%	354.54%	38.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001792849
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	12000
	hpk	Stock Issued During Period Shares Warrant Exercises StockIssuedDuringPeriodSharesWarrantExercises	965588
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2022Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021Q3	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
	hpk	Capitalized Exploratory Well Costs Maximum Term CapitalizedExploratoryWellCostsMaximumTerm	P1Y
	us-gaap	Capitalized Exploratory Well Cost Charged To Expense1 CapitalizedExploratoryWellCostChargedToExpense1	0	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2021Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	0	usd
CY2022Q3	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39464
	dei	Entity Registrant Name EntityRegistrantName	HighPeak Energy, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-3533602
	dei	Entity Address Address Line1 EntityAddressAddressLine1	421 W. 3rd St., Suite 1000
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	76102
	dei	Entity Address City Or Town EntityAddressCityOrTown	Fort Worth
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	City Area Code CityAreaCode	817
	dei	Local Phone Number LocalPhoneNumber	850-9200
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	113162827
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34348000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	83201000	usd
CY2022Q3	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	17261000	usd
CY2022Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	0	usd
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	50000	usd
CY2022Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	124021000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	101302000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	32230000	usd
CY2022Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	12806000	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	11071000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	13591000	usd
CY2022Q3	hpk	Advances From Joint Interest Owners For Costs Incurred On Joint Interest Wells AdvancesFromJointInterestOwnersForCostsIncurredOnJointInterestWells	7560000	usd
CY2021Q4	hpk	Advances From Joint Interest Owners For Costs Incurred On Joint Interest Wells AdvancesFromJointInterestOwnersForCostsIncurredOnJointInterestWells	10841000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3590000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	692000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	260350000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	103000000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	561756000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	97929000	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	111159000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	55802000	usd
CY2022Q3	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	8252000	usd
CY2021Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	4260000	usd
CY2022Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	4075000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	831000	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	113162827
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	113162827
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	96774185
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	96774185
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	617489000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-64436000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	553063000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	818960000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	121459000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	13629000	usd
	us-gaap	Production Tax Expense ProductionTaxExpense	5990000	usd
	us-gaap	Exploration Expense ExplorationExpense	1142000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	43737000	usd
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	116000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5042000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2894000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	72550000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	295688000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	253000	usd
	us-gaap	Interest Expense InterestExpense	29142000	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-42487000	usd
CY2022Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	-0	usd
CY2021Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	-0	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	127000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	23214000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4680000	usd
	us-gaap	Net Income Loss NetIncomeLoss	18534000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2022Q1	us-gaap	Dividends Cash DividendsCash	2434000	usd
CY2022Q1	hpk	Dividend Equivalents Per Share Declared DividendEquivalentsPerShareDeclared	0.025
CY2022Q1	hpk	Dividend Equivalents Cash DividendEquivalentsCash	250000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	156599000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	55000	usd
CY2022Q1	hpk	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	779000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	75000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2614000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-16510000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	693881000	usd
CY2022Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.025
CY2022Q2	us-gaap	Dividends Cash DividendsCash	2630000	usd
CY2022Q2	hpk	Dividend Equivalents Per Share Declared DividendEquivalentsPerShareDeclared	0.025
CY2022Q2	hpk	Dividend Equivalents Cash DividendEquivalentsCash	249000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	108383000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	3000	usd
CY2022Q2	hpk	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	6971000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	45000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16429000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	77561000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	900388000	usd
CY2022Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.025
CY2022Q3	us-gaap	Dividends Cash DividendsCash	2730000	usd
CY2022Q3	hpk	Dividend Equivalents Per Share Declared DividendEquivalentsPerShareDeclared	0.025
CY2022Q3	hpk	Dividend Equivalents Cash DividendEquivalentsCash	270000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	85000000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	232000	usd
CY2021Q1	hpk	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	5466000	usd
CY2022Q3	hpk	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	30000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	474226000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10655000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	107904000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	1100745000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1574000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	966000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	4744000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	486976000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1023000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	5743000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	493742000	usd
CY2021Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.125
CY2021Q3	us-gaap	Dividends Cash DividendsCash	11593000	usd
CY2021Q3	hpk	Dividend Equivalents Per Share Declared DividendEquivalentsPerShareDeclared	0.125
CY2021Q3	hpk	Dividend Equivalents Cash DividendEquivalentsCash	1193000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	905000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	8047000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	489908000	usd
	us-gaap	Net Income Loss NetIncomeLoss	168955000	usd
	us-gaap	Net Income Loss NetIncomeLoss	18534000	usd
	us-gaap	Exploration Abandonment And Impairment Expense ExplorationAbandonmentAndImpairmentExpense	134000	usd
	us-gaap	Exploration Abandonment And Impairment Expense ExplorationAbandonmentAndImpairmentExpense	698000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	94531000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	43737000	usd
	us-gaap	Accretion Expense Including Asset Retirement Obligations AccretionExpenseIncludingAssetRetirementObligations	245000	usd
	us-gaap	Accretion Expense Including Asset Retirement Obligations AccretionExpenseIncludingAssetRetirementObligations	116000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	29210000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2894000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3261000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	259000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4609000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	21656000	usd
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-19402000	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-55357000	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-4680000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	43822000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	16168000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7148000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7816000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	19130000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	21401000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	302806000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	87737000	usd
	us-gaap	Payments To Explore And Develop Oil And Gas Properties PaymentsToExploreAndDevelopOilAndGasProperties	725107000	usd
	us-gaap	Payments To Explore And Develop Oil And Gas Properties PaymentsToExploreAndDevelopOilAndGasProperties	154599000	usd
	hpk	Increase Decrease In Working Capital Associated With Oil And Natural Gas Property Additions IncreaseDecreaseInWorkingCapitalAssociatedWithOilAndNaturalGasPropertyAdditions	142299000	usd
	hpk	Increase Decrease In Working Capital Associated With Oil And Natural Gas Property Additions IncreaseDecreaseInWorkingCapitalAssociatedWithOilAndNaturalGasPropertyAdditions	15995000	usd
	us-gaap	Payments To Acquire Oil And Gas Property PaymentsToAcquireOilAndGasProperty	258385000	usd
	us-gaap	Payments To Acquire Oil And Gas Property PaymentsToAcquireOilAndGasProperty	53276000	usd
	us-gaap	Proceeds From Sale Of Oil And Gas Property And Equipment ProceedsFromSaleOfOilAndGasPropertyAndEquipment	0	usd
	us-gaap	Proceeds From Sale Of Oil And Gas Property And Equipment ProceedsFromSaleOfOilAndGasPropertyAndEquipment	3234000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	2158000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	453000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	-0	usd
	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	210179000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-843351000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-189099000	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	450000000	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	95000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	195000000	usd
	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	0	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	85000000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	9221000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1757000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	5466000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	120000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	7636000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	9274000	usd
	hpk	Payments Of Dividends Equivalents PaymentsOfDividendsEquivalents	908000	usd
	hpk	Payments Of Dividends Equivalents PaymentsOfDividendsEquivalents	829000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	540024000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	93776000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-521000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7586000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	34869000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19552000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	34348000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11966000	usd
	us-gaap	Interest Paid Net InterestPaidNet	18318000	usd
	us-gaap	Interest Paid Net InterestPaidNet	752000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Stock Issued1 StockIssued1	264982000	usd
	us-gaap	Stock Issued1 StockIssued1	0	usd
	us-gaap	Increase Decrease In Asset Retirement Obligations IncreaseDecreaseInAssetRetirementObligations	3748000	usd
	us-gaap	Increase Decrease In Asset Retirement Obligations IncreaseDecreaseInAssetRetirementObligations	1841000	usd
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	7200000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<b><i>Use of estimates in the preparation of financial statements. </i></b>Preparation of the Company's consolidated financial statements in<b><i> </i></b>conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Depletion of crude oil and natural gas properties and evaluations for impairment of proved and unproved crude oil and natural gas properties, in part, is determined using estimates of proved, probable and possible crude oil, NGL and natural gas reserves. There are numerous uncertainties inherent in the estimation of quantities of proved, probable and possible reserves and in the projection of future rates of production and the timing of development expenditures. Similarly, evaluations for impairment of proved crude oil and natural gas properties are subject to numerous uncertainties including, among others, estimates of future recoverable reserves, commodity price outlooks and future undiscounted and discounted net cash flows. In addition, evaluations for impairment of unproved crude oil and natural gas properties on a project-by-project basis are also subject to numerous uncertainties including, among others, estimates of future recoverable reserves, results of exploration activities, commodity price outlooks, planned future sales or expirations of all or a portion of such projects. Other items subject to such estimates and assumptions include, but are not limited to, the carrying value of crude oil and natural gas properties, asset retirement obligations, equity-based compensation, fair value of derivatives and estimates of income taxes. Actual results could differ from the estimates and assumptions utilized.
CY2022Q3	us-gaap	Income Tax Receivable IncomeTaxReceivable	3200000	usd
CY2021Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	3200000	usd
CY2022Q3	us-gaap	Oil And Gas Joint Interest Billing Receivables OilAndGasJointInterestBillingReceivables	3300000	usd
CY2021Q4	us-gaap	Oil And Gas Joint Interest Billing Receivables OilAndGasJointInterestBillingReceivables	3100000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<b><i>Concentration of credit risk. </i></b>The Company is subject to credit risk resulting from the concentration of its crude oil and natural gas receivables with significant purchasers. For the nine months ended September 30, 2022 and 2021, sales to the Company’s largest purchaser accounted for approximately 88% and 94%, respectively, of the Company’s total crude oil, NGL and natural gas sales revenues. The Company generally does not require collateral and does not believe the loss of this particular purchaser would materially impact its operating results, as crude oil and natural gas are fungible products with well-established markets and numerous purchasers in various regions.
CY2022Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	8200000	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	3300000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	649000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	438000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3548000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1600000	usd
	us-gaap	Capitalized Exploratory Well Cost Additions Pending Determination Of Proved Reserves CapitalizedExploratoryWellCostAdditionsPendingDeterminationOfProvedReserves	385440000	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	260400000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	103000000.0	usd
CY2021Q4	us-gaap	Capitalized Exploratory Well Costs CapitalizedExploratoryWellCosts	28076000	usd
	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	523400000	usd
CY2022Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	38098000	usd
CY2021Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-6844000	usd
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	21656000	usd
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-19402000	usd
CY2022Q3	hpk	Net Cash Receipts From Payments On Derivatives NetCashReceiptsFromPaymentsOnDerivatives	2300000	usd
CY2021Q3	hpk	Net Cash Receipts From Payments On Derivatives NetCashReceiptsFromPaymentsOnDerivatives	3976000	usd
	hpk	Net Cash Receipts From Payments On Derivatives NetCashReceiptsFromPaymentsOnDerivatives	64143000	usd
	hpk	Net Cash Receipts From Payments On Derivatives NetCashReceiptsFromPaymentsOnDerivatives	5014000	usd
CY2022Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	35798000	usd
CY2021Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-10820000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-42487000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-24416000	usd
	us-gaap	Reclassification To Well Facilities And Equipment Based On Determination Of Proved Reserves ReclassificationToWellFacilitiesAndEquipmentBasedOnDeterminationOfProvedReserves	319220000	usd
CY2022Q3	us-gaap	Capitalized Exploratory Well Costs CapitalizedExploratoryWellCosts	94296000	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	10212000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	-0	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	8032000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	2071000	usd
CY2022Q3	us-gaap	Long Term Debt LongTermDebt	561756000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	97929000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	561756000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	97929000	usd
CY2021Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	4260000	usd
	hpk	Asset Retirement Obligations Liabilities Assumed AssetRetirementObligationsLiabilitiesAssumed	3219000	usd
	us-gaap	Asset Retirement Obligation Liabilities Incurred AssetRetirementObligationLiabilitiesIncurred	528000	usd
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	245000	usd
CY2022Q3	us-gaap	Asset Retirement Obligation AssetRetirementObligation	8252000	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9705495
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.00
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y8M12D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	57942000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	442500
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	14.36
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	154268
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.00
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	10000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	10.00
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9983727
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.19
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y8M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	44395000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1564500
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	25.07
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	12000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	18999
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	18.66
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11517228
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.20
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y2M12D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	115484000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	8551070
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	10.13
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y8M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	38556000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	8551070
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	10.13
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y8M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	38556000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	11218914
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	12.00
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y2M12D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	114169000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	11218914
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	12.00
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y2M12D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	114169000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4680000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	116000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	349000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	465000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9000	usd
CY2021Q3	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2021Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	30599000	usd
CY2021Q3	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	2145000	usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	53726000	usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	4680000	usd
CY2022Q3	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	998000	usd
CY2021Q3	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1631000	usd
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	31597000	usd
CY2021Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2145000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	55357000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31597000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2145000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	55357000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4680000	usd
CY2022Q3	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	29295000	usd
CY2021Q3	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2140000	usd
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	47106000	usd
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	4875000	usd
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	592000	usd
CY2021Q3	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	20000	usd
	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	6128000	usd
	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-61000	usd
CY2022Q3	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	999000	usd
CY2021Q3	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	0	usd
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1723000	usd
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	0	usd
CY2022Q3	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	711000	usd
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-134000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31597000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2145000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	55357000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4680000	usd
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.227	pure
CY2021Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.210	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.247	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.202	pure
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6120000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	0	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4602000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2870000	usd
CY2022Q3	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	3612000	usd
CY2021Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	4373000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	3248000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	266000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	31000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	14600000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	10522000	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	124423000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	66324000	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	1336000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	-0	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	125759000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	66324000	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	111159000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	55802000	usd
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	107904000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	8047000	usd
	us-gaap	Net Income Loss NetIncomeLoss	168955000	usd
	us-gaap	Net Income Loss NetIncomeLoss	18534000	usd
CY2022Q3	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	10282000	usd
CY2021Q3	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	1193000	usd
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	16718000	usd
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	1669000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	97622000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6854000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	152237000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	16865000	usd
CY2022Q3	us-gaap	Dilutive Securities DilutiveSecurities	176000	usd
CY2021Q3	us-gaap	Dilutive Securities DilutiveSecurities	392000	usd
	us-gaap	Dilutive Securities DilutiveSecurities	300000	usd
	us-gaap	Dilutive Securities DilutiveSecurities	1000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	97798000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	7246000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	152537000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	16866000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108681000
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92676000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	102614000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92648000
CY2022Q3	hpk	Incremental Common Shares Attributable To Share Based Payment Arrangements And Warrants IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsAndWarrants	4315000
CY2021Q3	hpk	Incremental Common Shares Attributable To Share Based Payment Arrangements And Warrants IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsAndWarrants	2000
	hpk	Incremental Common Shares Attributable To Share Based Payment Arrangements And Warrants IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsAndWarrants	4408000
	hpk	Incremental Common Shares Attributable To Share Based Payment Arrangements And Warrants IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsAndWarrants	67000
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2122000
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2122000
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	115118000
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	92678000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109144000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	92715000
CY2022Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	371517
CY2022Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	3522117
CY2022Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	85000000.0	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3933376
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	21.61
	hpk	Stock Issued During Period Shares Warrants And Stock Options Exercised StockIssuedDuringPeriodSharesWarrantsAndStockOptionsExercised	980448
CY2022Q2	us-gaap	Dividends Dividends	2600000	usd
CY2022Q1	us-gaap	Dividends Dividends	2400000	usd
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	113162827
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	96774185
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	8287472
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	9500166
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50

Files In Submission

Name	View Source	Status
hpe20220930_10q_htm.xml	Edgar Link	completed
hpk-20220930_pre.xml	Edgar Link	unprocessable
hpk-20220930_cal.xml	Edgar Link	unprocessable
hpk-20220930_lab.xml	Edgar Link	unprocessable
hpk-20220930_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001437749-22-027261-index-headers.html	Edgar Link	pending
0001437749-22-027261-index.html	Edgar Link	pending
0001437749-22-027261.txt	Edgar Link	pending
0001437749-22-027261-xbrl.zip	Edgar Link	pending
ex_438280.htm	Edgar Link	pending
ex_438281.htm	Edgar Link	pending
ex_438282.htm	Edgar Link	pending
ex_438283.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hpe20220930_10q.htm	Edgar Link	pending
hpk-20220930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HPK
HighPeak Energy, Inc. Stock $hpk

2022 Q4 Form 10-Q Financial Statement

#000143774922027261 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HPK HighPeak Energy, Inc. Stock $hpk

2022 Q4 Form 10-Q Financial Statement

#000143774922027261 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HPK
HighPeak Energy, Inc. Stock $hpk